ASX - By Stock
|
MSB |
Re:
TEMCELL® HS Inj
|
|
otherperspective
|
11 |
6.7K |
51 |
23/03/19 |
23/03/19 |
ASX - By Stock
|
11
|
6.7K
|
51
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
otherperspective
|
4.4K |
2.4M |
5 |
14/03/19 |
14/03/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
msb
|
|
otherperspective
|
15 |
7.3K |
20 |
25/02/19 |
25/02/19 |
ASX - By Stock
|
15
|
7.3K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Provides Half Year Results and Corporate Update
|
|
otherperspective
|
84 |
28K |
32 |
21/02/19 |
21/02/19 |
ASX - By Stock
|
84
|
28K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
MSB short selling data - 25th.Jan.2019
|
|
otherperspective
|
100 |
38K |
21 |
06/02/19 |
06/02/19 |
ASX - By Stock
|
100
|
38K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
laughable
|
|
otherperspective
|
39 |
16K |
8 |
13/01/19 |
13/01/19 |
ASX - By Stock
|
39
|
16K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
|
|
otherperspective
|
101 |
36K |
28 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
101
|
36K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Potential Market Size for Mesoblast products in US
|
|
otherperspective
|
24 |
7.1K |
10 |
08/01/19 |
08/01/19 |
ASX - By Stock
|
24
|
7.1K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Potential Market Size for Mesoblast products in US
|
|
otherperspective
|
24 |
7.1K |
3 |
07/01/19 |
07/01/19 |
ASX - By Stock
|
24
|
7.1K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
otherperspective
|
4.4K |
2.4M |
17 |
02/01/19 |
02/01/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
3 |
28/12/18 |
28/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
9 |
28/12/18 |
28/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
14 |
28/12/18 |
28/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
otherperspective
|
63 |
25K |
12 |
27/12/18 |
27/12/18 |
ASX - By Stock
|
63
|
25K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
otherperspective
|
63 |
25K |
19 |
24/12/18 |
24/12/18 |
ASX - By Stock
|
63
|
25K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
otherperspective
|
63 |
25K |
34 |
24/12/18 |
24/12/18 |
ASX - By Stock
|
63
|
25K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast Estimates Annual Peak Sales For AGVHD To Be About $700 Million In United States...
|
|
otherperspective
|
19 |
6.1K |
40 |
20/12/18 |
20/12/18 |
ASX - By Stock
|
19
|
6.1K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
20 |
19/12/18 |
19/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
16 |
18/12/18 |
18/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Is GI bleeding a worthwhile treatment indication?
|
|
otherperspective
|
15 |
8.7K |
26 |
16/12/18 |
16/12/18 |
ASX - By Stock
|
15
|
8.7K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Is GI bleeding a worthwhile treatment indication?
|
|
otherperspective
|
15 |
8.7K |
1 |
15/12/18 |
15/12/18 |
ASX - By Stock
|
15
|
8.7K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
15 |
14/12/18 |
14/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
7 |
14/12/18 |
14/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
13 |
14/12/18 |
14/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
20 |
14/12/18 |
14/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MSB monthy chart (over 14 years)
|
|
otherperspective
|
79 |
26K |
15 |
11/12/18 |
11/12/18 |
ASX - By Stock
|
79
|
26K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MSB monthy chart (over 14 years)
|
|
otherperspective
|
79 |
26K |
15 |
11/12/18 |
11/12/18 |
ASX - By Stock
|
79
|
26K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
22 |
04/12/18 |
04/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
26 |
29/11/18 |
29/11/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
otherperspective
|
3.4K |
1.3M |
18 |
29/11/18 |
29/11/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
CBS in New York today - GvHD
|
|
otherperspective
|
6 |
3.2K |
17 |
21/11/18 |
21/11/18 |
ASX - By Stock
|
6
|
3.2K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MSB chart
|
|
otherperspective
|
951 |
309K |
20 |
21/11/18 |
21/11/18 |
ASX - By Stock
|
951
|
309K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
And then everyone panic sells
|
|
otherperspective
|
75 |
25K |
22 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
75
|
25K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Let me clarify
|
|
otherperspective
|
73 |
33K |
25 |
12/11/18 |
12/11/18 |
ASX - By Stock
|
73
|
33K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Massive news coming
|
|
otherperspective
|
32 |
13K |
29 |
03/11/18 |
03/11/18 |
ASX - By Stock
|
32
|
13K
|
29
|
|